Phase 2 Aspergillosis Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
Rezafungin for Treatment of Chronic Pulmonary Aspergillosis (CPA) in Adults With Limited Treatment Options
Chronic Pulmonary Aspergillosis
Mundipharma Research Limited60 enrolled37 locationsNCT06794554
Recruiting
Phase 2
iMagIng pulmonaRy Aspergillosis Using Gallium-68-dEferoxamine
Allergic Bronchopulmonary AspergillosisChronic Pulmonary AspergillosisPulmonary Aspergillosis
Radboud University Medical Center10 enrolled1 locationNCT06244979
Recruiting
Phase 2
Interferon-gamma as Adjunctive Therapy in Chronic Pulmonary Aspergillosis: a Randomised Feasibility Study
AspergillosisChronic Pulmonary Aspergillosis
Manchester University NHS Foundation Trust50 enrolled1 locationNCT05653193
Completed
Phase 2Phase 3
Omalizumab for Chronic Allergic Bronchopulmonary Aspergillosis: a randomised, placebo-controlled crossover trial
Allergic Bronchopulmonary Aspergillosis
Jo Douglass14 enrolled1 locationACTRN12613000278730